| Product Code: ETC9562138 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of peptide drug conjugates to Sweden in 2024 were primarily sourced from neighboring countries including Denmark, Belgium, Germany, Netherlands, and Italy. Despite the presence of multiple exporting countries, the market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained low in 2024. The compound annual growth rate (CAGR) for the period 2020-2024 was steady at 4.69%, indicating a consistent expansion of the market. Furthermore, the notable growth rate of 17.54% from 2023 to 2024 suggests a potential surge in demand for peptide drug conjugates in the Swedish market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Peptide Drug Conjugates Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Peptide Drug Conjugates Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Peptide Drug Conjugates Market - Industry Life Cycle |
3.4 Sweden Peptide Drug Conjugates Market - Porter's Five Forces |
3.5 Sweden Peptide Drug Conjugates Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Sweden Peptide Drug Conjugates Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 Sweden Peptide Drug Conjugates Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing demand for targeted cancer therapies |
4.2.2 Increasing investments in research and development of peptide drug conjugates |
4.2.3 Favorable government regulations supporting peptide drug conjugates market growth |
4.3 Market Restraints |
4.3.1 High development costs and complexities associated with peptide drug conjugates |
4.3.2 Limited awareness and adoption of peptide drug conjugates in certain medical conditions |
5 Sweden Peptide Drug Conjugates Market Trends |
6 Sweden Peptide Drug Conjugates Market, By Types |
6.1 Sweden Peptide Drug Conjugates Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Sweden Peptide Drug Conjugates Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Sweden Peptide Drug Conjugates Market Revenues & Volume, By OctreoScan, 2021- 2031F |
6.1.4 Sweden Peptide Drug Conjugates Market Revenues & Volume, By Lutathera, 2021- 2031F |
6.1.5 Sweden Peptide Drug Conjugates Market Revenues & Volume, By Pepaxto, 2021- 2031F |
6.1.6 Sweden Peptide Drug Conjugates Market Revenues & Volume, By ANG1005, 2021- 2031F |
6.1.7 Sweden Peptide Drug Conjugates Market Revenues & Volume, By BT1718, 2021- 2031F |
6.2 Sweden Peptide Drug Conjugates Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden Peptide Drug Conjugates Market Revenues & Volume, By Therapeutic, 2021- 2031F |
6.2.3 Sweden Peptide Drug Conjugates Market Revenues & Volume, By Diagnostic, 2021- 2031F |
7 Sweden Peptide Drug Conjugates Market Import-Export Trade Statistics |
7.1 Sweden Peptide Drug Conjugates Market Export to Major Countries |
7.2 Sweden Peptide Drug Conjugates Market Imports from Major Countries |
8 Sweden Peptide Drug Conjugates Market Key Performance Indicators |
8.1 Number of clinical trials using peptide drug conjugates |
8.2 Research funding allocated to peptide drug conjugates |
8.3 Adoption rate of peptide drug conjugates in targeted therapies |
9 Sweden Peptide Drug Conjugates Market - Opportunity Assessment |
9.1 Sweden Peptide Drug Conjugates Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Sweden Peptide Drug Conjugates Market Opportunity Assessment, By Type, 2021 & 2031F |
10 Sweden Peptide Drug Conjugates Market - Competitive Landscape |
10.1 Sweden Peptide Drug Conjugates Market Revenue Share, By Companies, 2024 |
10.2 Sweden Peptide Drug Conjugates Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |